Search is Powered by Google
Cancer / Oncology News

How To Move Cancer Research Forward: Public/Private Partnerships - A NCI Science Writer's Seminar

Main Category: Cancer / Oncology
Also Included In: Conferences
Article Date: 02 Jul 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts
What
br> Please join us for a science writers' seminar to discuss public/private partnerships in cancer research. Among the topics discussed will be working with industry to develop new drugs; cancer vaccine development and business barriers; working with small businesses to develop new technologies to catch cancer in its earliest stages; and intellectual property rights and technology transfer issues related to new genetic tests. The seminar will be in a classroom setting with ample time for Q&A and interaction during the talks.

Who

Leading experts from the National Cancer Institute (NCI), including:

John E. Niederhuber, M.D., Director
James Doroshow, M.D., Director, Division of Cancer Treatment and Diagnosis
Jeffrey Schlom, Ph.D., Chief, Laboratory of Tumor Immunology and Biology
Michael Weingarten, M.A., Director, Small Business Programs
Karen Maurey, M.A., Director, Technology Transfer Center
Jason Cristofaro, Ph.D., J.D., Intellectual Property Advisor

When

Monday, July 28, 2008: 8:45 a.m. - 11:30 a.m. (EDT)
Registration will be at 8:45 a.m. Talks by experts will begin at 9:00 a.m. A coffee break will occur about 10:15 a.m.

Where

NIH, Natcher Conference Center, Rooms F1/F2
9000 Rockville Pike, Bethesda, Md.
Attendees are strongly encouraged to use the Metro. The NIH campus can be easily accessed via the Medical Center stop on the Metro's Red Line. For transportation, parking and security at NIH, go to http://www.nih.gov/about/visitorsecurity.htm.

How

Please register for the seminar by contacting the NCI Office of Media Relations at (301) 496-6641 or ncipressofficers@mail.nih.gov.

National Cancer Institute




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...